MA

Md Ajaz Alam

Active Director Director DIN 09288252
DIN 09288252 First appointment Sep 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Md Ajaz Alam

Data last updated:

Md Ajaz Alam is a Director at Lupus Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Lupus Pharmaceuticals Private Limited reported revenue of ₹31.8 Lakh (FY 2024).

DIN 09288252
Primary Designation Director
Industry Chemicals
First Appointment 08 Sep 2021
Oldest Company Age 5 yrs
Largest company Lupus Pharmaceuticals Private Limited · ₹31.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Sep 20212021₹31.8 Lakh (FY 2024)Active

Board colleagues of Md Ajaz Alam

NameDINCompanyDesignation
Md Ishtiyaque09288358Lupus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lupus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Md Ajaz Alam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Md Ajaz Alam

Md Ajaz Alam currently holds 1 directorship: Lupus Pharmaceuticals Private Limited (Director, since 08 Sep 2021, revenue ₹31.8 Lakh (FY 2024)).

Md Ajaz Alam was first appointed on 08 Sep 2021 as Director at Lupus Pharmaceuticals Private Limited.

The current boards of Md Ajaz Alam's companies include Md Ishtiyaque (Lupus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available